Techstart Ventures is a venture capital firm based in Belfast, United Kingdom, founded in 2014. It focuses on early-stage investments, supporting founders from pre-seed through Series A who pursue globally scalable opportunities in Scotland and Northern Ireland. The firm often leads or co-leads initial rounds and provides follow-on capital, backing teams with strong potential, unique insights, and clear vision. Techstart emphasizes rapid learning, measurable progress, and active engagement with portfolio companies to accelerate growth; it targets founders at the earliest stages, even before substantial product-market fit or revenue, to foster ambitious, long-term outcomes.

Clarendon Fund Managers is a Belfast-based venture capital firm focused on supporting small and medium-sized enterprises in Northern Ireland through early- and growth-stage investing. It pursues co-investments with business angels and private investors and may collaborate with public partners to provide capital and strategic guidance to portfolio companies across sectors such as consumer products and services, healthcare, information technology, cybersecurity, industrials, and other technology-enabled industries. Typical initial commitments range from £20,000 to £250,000, with follow-on financing available at later stages, and the firm looks to exit investments within roughly five to seven years. Founded in 2001, it has backed numerous regional companies, contributing to regional innovation and economic development.

SOSV is a global venture capital firm founded in 1995 and headquartered in New Jersey. The firm focuses on seed-to-growth investments in deep tech sectors, including biotech and life sciences, hardware and robotics, and cross-border software with emphasis on markets in Asia. It supports startups from early stages with investment capital as well as resources such as laboratories, collaborative spaces, and expert mentorship to accelerate product development and market traction. SOSV operates purpose-built programs to help portfolio companies raise follow-on funding, scale operations, and reach customers, often through structured matchmaking and access to a global network of investors. With a broad portfolio spanning hundreds of companies worldwide, SOSV aims to foster innovation, build vibrant entrepreneurial ecosystems, and contribute to sustainable technological advancement.

Act Venture Capital is a Dublin-based technology-focused venture capital firm formed in 1994 that provides capital and strategic support to early-stage and growth companies across Europe. The firm backs technology and healthcare companies across markets including Ireland and wider Europe, investing from seed to growth and focusing on categories such as software, IT infrastructure, communications, Internet and mobile. Act partners with founders to help scale globally, drawing on a network of US and European investors and a track record of building category-defining businesses. The firm emphasizes hands-on guidance, access to capital, and long-term value creation, including support from partners and the European Investment Fund in recent funds. Act maintains a relatively small, diverse team with deep industry experience and a collaborative approach to portfolio development, aiming to help portfolio companies accelerate product development, accelerate go-to-market, and expand internationally.

Frontline Ventures is a venture capital firm headquartered in Dublin with an office in London and a presence in San Francisco. It backs globally ambitious B2B software companies on both sides of the Atlantic, supporting them from early stages through growth and international expansion. The firm focuses on cross-border expansion into the United States and Europe, leveraging a network of experienced operators and founders to help navigate cross-border growth, and it uses its research and playbooks to guide portfolio companies through market entry and scaling. Frontline emphasizes value creation through its global reach and operational experience, with investments spanning sectors such as AI, fintech, healthcare and logistics. The firm aims to help founders reach major milestones, including IPOs, by providing strategic guidance, hands-on support, and access to a broad international network.

Par Equity is a venture capital and private equity firm backed by Scottish Enterprise, based in Edinburgh with an office in San Francisco. It specializes in early‑stage and growth investments in technology companies, including software, deep tech and digital health, targeting opportunities in Scotland, Northern England and Northern Ireland, with cross‑border expansion between the United Kingdom and the United States. The firm funds proprietary technology and proven products poised for international growth, supporting UK companies expanding to the United States and US entrants seeking a UK presence. Typical investments range from £0.25 million to £2.5 million, with enterprise values up to about £10 million. It also provides angel capital to investee companies and focuses on cross‑border deals to accelerate scale.

Norwest is a venture capital and growth equity investment firm that focuses on venture and growth-stage companies. Since its inception, it has invested in more than 600 companies and partnered with over 140 active companies across its venture and growth equity portfolio. The firm backs early to late-stage companies across sectors with a focus on consumer, enterprise, and healthcare, and it provides a deep network of connections, operating experience, and a broad range of services to help CEOs and founders scale their businesses.

Kernel Management Partners is a private equity and venture capital firm based in Cork, Ireland, with additional offices in Dublin and Belfast. It provides equity financing to technology companies across Ireland, supporting seed, early, growth, and expansion-stage opportunities, including support for mergers, acquisitions, and management buyouts. The firm focuses on knowledge-based technology sectors such as information and communications technology, software and web, telecommunications, big data, and related areas, aiming to back companies with scalable products, strong intellectual property, and significant growth potential.

Elkstone is a Dublin-based Irish investment firm specializing in private markets. It focuses on serving entrepreneurs, senior executives, institutional LPs, the venture community, and the Irish diaspora, with a mission to grow Ireland’s economic value and overall wellbeing by expanding its network, enabling suitable investments, and delivering strong investment performance. The firm emphasizes providing access to private markets and related advisory services for investors, founders, and financial advisors, supported by a team of specialists. Its approach centers on connectivity, expertise, and delivering results that benefit the broader Irish ecosystem.

Fountain Healthcare Partners is an Ireland-headquartered private equity and venture capital firm specializing in the life sciences sector. Based in Dublin with an office in New York, it focuses on companies developing biotechnology, biopharmaceuticals, specialty pharmaceuticals, medical devices, and diagnostics, investing primarily in Europe and the United States. The firm supports early-stage through growth-stage companies, providing capital and strategic guidance to help advance therapies and enabling technologies through key milestones. Its team combines scientific and business expertise to assess science, market dynamics, and regulatory pathways, with a track record of active involvement and governance, including board participation. Fountain Healthcare Partners seeks to back visionary founders addressing unmet medical needs and to accelerate meaningful healthcare innovations over multi-year horizons.

Seroba Life Sciences is a Dublin-based venture capital firm focused on life sciences and medical technology. Founded in 2002, it invests in therapeutics, diagnostics, and medical devices across Western Europe and North America, from seed through late-stage development. The firm typically leads or co-leads investments, often in the range of several million euros, and provides support through inception, clinical development, regulatory approvals, intellectual property creation, and market launch. It emphasizes backing ambitious entrepreneurs and innovative technologies that aim to improve patient outcomes, with offices in Ireland and the United Kingdom to support global opportunities.

OakNorth is a UK-based digital bank and fintech that focuses on servicing growth-oriented small-to-medium-sized businesses traditionally underserved by banks. It provides bespoke debt finance solutions, including secured and unsecured loans, without requiring equity in exchange, and uses data-driven credit analytics and forward-looking scenario planning to support growth across sectors such as property development, hospitality, care, and education. The company positions itself as a long-term funding partner, emphasizing reliable, repeat lending and referrals. It leverages analytical tools, including OakNorth Analytical Intelligence and OakNorth Credit Intelligence, to manage risk and enable sustainable lending decisions. The bank has lent billions in the UK and supports job creation and housing while offering digital banking services and savings products to business and personal customers.

Delta Partners is a venture capital firm founded in 1994 and based in Dublin, Ireland, with an additional office in London. It concentrates on early‑stage technology startups in Ireland and the United Kingdom, often backing spin‑offs from development teams or campus companies. The firm typically invests in information technology and information and communications technology, as well as healthcare and life sciences ventures, including pharmaceuticals, medical technology, and other health‑tech products and services, supporting portfolio companies at the initial growth stage.

Growing Capital is a venture capital firm based in Dublin, Ireland, founded in 2015. It invests in software and business-to-business technology companies, focusing on seed and early-stage opportunities across Ireland.

Sure Valley Ventures is a London-based venture capital firm focused on early-stage AI and software startups across the United Kingdom and Ireland. Founded in 2017 by a team of former founders turned investors, SVV leverages entrepreneurial experience to back high-potential companies that apply foundational AI technologies to solve real-world industry problems.

COSIMO Ventures is an early-stage venture capital firm focused on disruptive technology, with activities in Ireland and the United Kingdom and offices in Boston and Dublin. The team brings extensive entrepreneurial and investing experience and works with management teams to accelerate growth and help Irish and UK technology companies reach global markets, including expansion into the United States. As technology pioneers, COSIMO Ventures emphasizes value creation for early-stage companies and supports founders with strategic guidance, networks, and hands-on operational insight to help them build scalable, world-leading businesses.

Lough Shore Investments is a venture capital firm based in Belfast, Ireland. It invests in startups in the web, mobile, and enterprise sectors with a focus on opportunities in Northern Ireland and Ireland, and seeks to partner with high-potential management teams to build scalable businesses, including established and next-generation startups. Its stated goal is to help portfolio companies reach exits or initial public offerings, with a plan to bring ten companies to exit or IPO by 2025.

eDot Invest is a Dublin-based venture capital firm founded in 2014 that specializes in early-stage technology investments in Europe. The firm provides capital and ongoing support to startups to help them develop products, expand operations, and scale their businesses.

Crescent Capital is a Belfast-based venture capital firm focused on Northern Ireland technology, life sciences, manufacturing, and related sectors. It provides equity investments across early to growth stages, typically starting from around £0.45 million and up to £1.2 million initially, with total commitments up to about £3 million per company. The firm pursues both majority and minority positions and often assumes a non-executive director seat to guide portfolio companies. It offers strategic input, industry contacts, and capital support to help high-growth businesses scale. Founded in 1995, Crescent Capital operates from Belfast with an additional London office and concentrates on building value through exits in five to seven years, commonly via trade sale, while strengthening Northern Ireland's entrepreneurial ecosystem.

Irrus Investments is an Irish business angel network based in Limerick that supports early-stage Irish companies in medical devices, diagnostics, digital healthcare, and life sciences. It provides mentorship and funding to startups, often ranging from €500,000 to €1 million, and frequently collaborates with venture capital firms for larger rounds. The network emphasizes practical guidance and entrepreneurship across Ireland, and operates on a non-profit basis, serving as a resource for both investors seeking opportunities and startups seeking capital to realize their plans.

European Investment Fund is the EU's financing arm for small and medium-sized enterprises and mid-caps, providing financial instruments to improve access to affordable financing for businesses across their lifecycle, with a focus on innovation, growth, competitiveness, social impact and sustainability. The EIF leverages its capital base to foster public-private partnerships and allocates guarantees and equity funding to catalyze lending and investment for startups and small businesses throughout Europe, including EU member states, candidate countries and EFTA countries. It collaborates with partners to close funding gaps and support entrepreneurship and economic resilience.

TCV is a global investment firm that provides capital and strategic support to growth-stage technology companies. Founded in 1995 and headquartered in Menlo Park, California, the firm has deployed billions of dollars in hundreds of technology companies. It combines capital with data-driven insights, sector expertise, access to top talent, and connections with category leaders to accelerate growth. TCV invests across multi-stage structures and growth expansions in sectors including internet, software, information technology, big data, cybersecurity, fintech, e-commerce, and infrastructure. Typical equity investments range from tens to hundreds of millions. The firm's portfolio spans notable companies such as Netflix and other tech leaders, with ongoing activity in the United States and the United Kingdom. TCV pursues long-term partnerships, helping portfolio companies scale, innovate, and transform their industries through strategic collaboration.

Enterprise Equity Venture Capital is an Ireland-based venture capital firm with offices in Dublin, Cork, Galway and Dundalk. It backs early-stage and expanding technology companies, with a focus on software, high-tech manufacturing and medical devices, and supports international growth. The firm manages three funds and has invested in more than 80 companies across Ireland, typically investing up to €1.5 million per business and participating in seed investments through a €53 million fund. It co-invests with international venture capital partners and has operated for over 25 years. The company is regulated by the Central Bank of Ireland under MiFID.

BGF is a UK-based growth equity firm established in 2011 that provides patient capital and comprehensive support to ambitious small and mid-sized companies across the UK and Ireland. It targets deep tech and life sciences sectors and invests from late-seed to Series B stages, aiming to turn science-led innovation into global success. Beyond funding, BGF offers extensive networks, resources, and growth expertise, including assistance with follow-on financing and strategic growth initiatives. The firm pursues long-term partnerships, typically avoiding controlling equity stakes, and has deployed more than £4.5 billion in growth capital to date.

MVM Partners is a growth equity investment firm focused on healthcare sectors including medical technology, pharmaceuticals, diagnostics, life sciences and digital health. Founded in 1997 and headquartered in London with an office in Boston, it pursues early- to growth-stage opportunities across global markets, supporting management teams with investments typically ranging from $20 million to $100 million to drive product development and market differentiation. The firm emphasizes differentiated technology, patent protection, and unmet medical needs, aiming for strategic exits through acquisitions or initial public offerings, and it manages over $1 billion in assets with a team possessing extensive healthcare investment experience.

Lightstone Ventures is a California-headquartered global venture capital firm that funds early- and growth-stage life sciences companies, including biopharmaceuticals, personalized medicines, and medical devices. Founded in 2012 by senior members of Advanced Technology Ventures and Morgenthaler, the firm emphasizes patient-focused innovation and provides hands-on partnership and strategic guidance throughout a company’s lifecycle from startup to commercialization. Its investment focus spans disruptive therapeutics and medical technologies in areas such as central nervous system disorders, immunology, oncology, ophthalmology, cardiovascular and neurology, as well as other unmet medical needs. Lightstone pursues a global footprint with offices in the United States and Ireland, and participates in incubation programs to support portfolio companies. The firm seeks opportunities across the United States, Europe and beyond, pairing capital with operational experience to help companies accelerate development and reach meaningful patient impact.

Business Venture Partners is an Ireland-based private equity and corporate finance firm, founded in 2004. The firm provides flexible investment options from seed equity to project financing for Irish companies across sectors including energy, healthcare, engineering, climate action, mobility and information technology. It employs both equity and debt financing to support growth, expansion, and strategic initiatives, with a focus on sustainability and shareholder value. The team delivers hands-on support to founders and management, helping accelerate growth, navigate international expansion, and build resilient businesses. With roots in corporate finance advisory for SMEs and owner-managed businesses, BVP combines industry knowledge with venture investing to back high-potential ventures and enable sustainable, long-term performance in the Irish market.

CircleRock Capital is a London- and Dublin-based venture capital firm founded in 2020 that operates as a multi-stage investor focused on technology companies across Europe, the UK, and the US. The firm pursues a conviction-driven, deal-by-deal approach, co-investing with others to back Seed through Series B rounds and seeking meaningful ownership. Typical initial tickets range from €500,000 to €5 million. CircleRock does not typically lead rounds or take board seats and has built a portfolio of about 25 companies. The firm emphasizes leveraging its commercial and talent networks to access competitive opportunities. Its footprint across Europe and North America reflects a global technology investment strategy.

Treo Ventures is a healthcare-focused venture capital firm established in 2018 and based in Santa Clara, California, with operations in Silicon Valley and Ireland. The firm invests globally in early to commercial-stage companies advancing medical devices, digital health, and therapeutic technologies that address unmet clinical needs, particularly in cardiovascular, orthopedic, and neuromodulation applications. It brings decades of healthcare investment and operating experience and provides strategic guidance to portfolio companies, supported by an accelerator program named NuXcel. Treo Ventures seeks high-growth opportunities and collaborates with portfolio companies such as ShiraTronics, Avivomed, and SecondWave Systems to accelerate product development and market adoption.

Ascension is a large nonprofit Catholic health system serving communities across Florida, Illinois, Indiana, Kansas, Maryland, Oklahoma, Tennessee, Texas, Wisconsin, and beyond, comprising 94 hospitals and 23,000 affiliated providers. It is dedicated to delivering compassionate, accessible care and offers a broad range of services and specialties, including pediatric care, oncology, and genetic testing. The system emphasizes patient portals for accessing medical records and secure online billing, price transparency, interpreter services in multiple languages, and community health initiatives. It supports initiatives such as music therapy for newborns and emotional support for patients, while encouraging volunteerism and philanthropy to sustain clinical and community programs.

General Catalyst is a venture capital firm founded in 2000 and based in Cambridge, Massachusetts, with additional offices in North America and Europe. It provides seed to growth-stage investments in technology companies, with emphasis on software, consumer and enterprise applications, fintech, crypto, health tech, and AI-enabled businesses. The firm supports portfolio companies with capital, strategic guidance, mentorship and operational assistance to help them scale and innovate across industries, including healthcare, fintech and consumer technology. General Catalyst manages multiple venture funds and pursues both early-stage and growth investments, often taking minority to majority equity positions. The firm has a global reach and a history of backing companies that become industry leaders, with ongoing focus on resilience and applied AI.

Founded in 2020, the European Innovation Council is a Brussels-based venture capital initiative that supports top innovators, entrepreneurs, small companies, and researchers with bright ideas. It co-invests with private investors in early-stage startups, prioritizes deep technology ventures, and pursues ESG-positive impacts to accelerate commercialization and scale-up.

57 Stars is a global independent asset manager specializing in private equity and venture capital investments, focusing on primary and secondary private equity partnerships and co-investments outside the United States, with emphasis on emerging markets. The firm applies a rigorous, analytical approach and a global perspective to identify opportunities across direct investments, funds of funds, and co-investments, serving institutional clients and pursuing responsible investing and long-term growth.

4th Level Ventures is a Dublin-based venture capital firm founded in 2002 that invests in technology companies across Western Europe. The firm prioritizes opportunities where intellectual property originates from university or research institution work and aims to commercialize academic innovations. It seeks to support growth by combining relationships with business leaders, investors, universities, and financial institutions to bring university-originated technologies to market. The approach includes collaboration with university commercialization teams and engaging academics early to evaluate propositions and aid in commercial decision-making, helping translate research outputs into viable businesses. The firm focuses on technology sectors and operates across Western Europe, leveraging academic partnerships to identify and nurture disruptive technologies.

Hercules Capital is a specialty finance company that provides venture debt and senior secured loans to venture capital-backed companies across technology and life sciences. It focuses on structured debt and growth capital, offering financing options such as working capital facilities, equipment loans, and other debt instruments to high-growth, expansion-stage firms, complementing equity rounds and allowing companies to extend runways while preserving ownership. The firm primarily invests in United States-based companies across software, hardware, semiconductors, healthcare, and related sectors, including energy technology and information services. Exits are pursued through initial public offerings, private sales, mergers or acquisitions, or other liquidity events. Known for sector expertise and a broad capital base, it emphasizes flexible, customized financing solutions that align with a portfolio company's milestones and capital structure needs.

True Ventures is a Silicon Valley venture capital firm founded in 2005 and based in Palo Alto, California. It specializes in early-stage technology startups, providing seed and Series A financing to entrepreneurs in the United States. The firm emphasizes active founder support through The True Platform, which offers programs to inspire professional and personal growth for portfolio companies. True Ventures maintains a team of experienced professionals and advisers and has backed more than 350 companies, helping to create 85,000 jobs worldwide. The firm manages more than $3.8 billion in capital across multiple funds and has been recognized for its contributions to the entrepreneurship ecosystem, including being named Venture Firm of the Year in 2018 by the National Venture Capital Association.

Zoosh Group is a product studio and early-stage investor specializing in design-led cloud solutions. It combines venture-style guidance with hands-on product development, offering investment, digital product design, build and development, and ongoing support to help startups move from idea to launch and scale. Through a team of experienced business coaches, Zoosh assists with refining cloud propositions, building teams, and creating new revenue streams. Founded in 2017 and headquartered in Ireland, the firm focuses on helping entrepreneurs create profitable, scalable businesses that leverage cloud-enabled designs.

Lucey Fund is a venture capital firm based in Dublin, Ireland, founded in 2011, that invests in technology ventures and supports entrepreneurs who may not have prior technology experience but possess industry knowledge. It funds the development of first scalable, secure, viable products and provides a multidisciplinary team of technology, marketing and sales experts to research, design, build, host, finance and commercialize the product and the business.

Pxn Ventures is a UK-based venture capital firm formed by the merger of Praetura Investments and Par Equity. It focuses on supporting startups in the North of England, Northern Ireland, and Scotland, leveraging decades of experience and extensive networks. The firm emphasizes a holistic approach that goes beyond financing by providing founder support through operational partners and ongoing investor updates to help build sustainable, high-growth businesses.

Wayra is Telefónica's global corporate venture capital arm and open innovation hub. It operates in ten countries—Argentina, Brazil, Chile, Colombia, Germany, Mexico, Peru, Spain, the United Kingdom, and Venezuela—connecting startups with Telefónica to generate joint business opportunities. Wayra acts as the interface between Telefónica and entrepreneurial ecosystems, providing investment, acceleration programs, and partnerships with Telefónica's businesses to help startups scale and access global markets. The program focuses on digital transformation in sectors such as healthcare, finance, and logistics, leveraging AI and IoT to drive innovative solutions, supported by Wayra's networks and capital within a broad international ecosystem.

ACF Investors is a United Kingdom based venture capital firm that partners with experienced angel investor groups to support ambitious entrepreneurs in the UK across diverse industries, including healthcare, technology, and financial services. By combining capital with advisory expertise, the firm helps early-stage companies grow and scale, emphasizing long-term value creation and ongoing mentorship through collaborative co-investment with angels.

Draper Esprit is a Europe-focused private equity and venture capital firm with offices in London, Cambridge, Dublin, Helsinki, and Paris. It backs technology-oriented businesses and healthcare across Europe at multiple stages—from seed and Series A to growth and pre-IPO—placing both minority and majority stakes. The firm pursues direct investments and secondary opportunities in sectors including software, hardware, fintech, internet, digital health, and other tech-enabled areas, targeting companies in the UK, Ireland, and wider Europe.

Finistere Ventures is a venture capital firm focused on agriculture, agtech and life sciences. Founded in 2005, it operates from the West Coast with offices in San Diego and Newport Beach, California, and additional locations in Palo Alto, Menlo Park, Dublin and Tel Aviv, reflecting a global investment footprint. The firm backs private companies across the United States and selected international markets, supporting opportunities from early stage to growth stage in sectors such as agricultural biotechnology, crop protection, precision agriculture, food technology, plant and animal health, bioproducts and sustainability tools. Finistere engages with portfolio companies to accelerate product development, scale operations and access strategic partnerships, often through co-investment and mentorship networks. By leveraging global networks and sector expertise, the firm seeks to advance productivity, food security and environmental sustainability while building companies with meaningful potential for value creation and exits.

CIBC Innovation Banking is a division of CIBC that serves entrepreneurs and investors in the innovation economy. Backed by CIBC, it offers financial capital, a broad network of connections, and insightful service to help growth-oriented companies and their investors secure funding, form partnerships, and scale operations. The bank's team combines capital solutions with practical guidance and access to a wide ecosystem of industry partners to support startups and venture-backed businesses through key growth stages.

Cross Atlantic Capital Partners is a Radnor, Pennsylvania-based venture capital firm focused on technology-driven companies across the United States, Ireland, and the United Kingdom. It targets early to mid-stage opportunities in software, IT services, telecommunications, financial services, and other technology-enabled sectors, often backing companies with patented know-how or distinctive expertise. The team combines deep operational experience, with multiple partners having held CEO or COO roles, and maintains active involvement on portfolio company boards. It leverages an extensive cross-Atlantic network and relationships with strategic partners, lenders, and industry groups to support growth and value creation. The firm seeks opportunities with large markets and potential to achieve meaningful revenue or valuation milestones within three to five years, providing strategic guidance and board-level oversight to help accelerate development and scale.

Impax Asset Management Group is a specialist asset manager focused on investing in the transition to a sustainable global economy. It offers listed and private market strategies to institutional clients, managing funds and accounts across environmental markets such as alternative energy, water, and waste, with a focus on the energy transition. The firm combines fundamental analysis with ESG factors to inform portfolio construction and risk management, and its offerings include active long-only equity, fixed income, infrastructure (New Energy) and smart beta strategies. Headquartered in London, it serves clients worldwide, including North America and Europe, and maintains a global footprint across multiple regions. The company aims to deliver long-term, risk-adjusted returns aligned with sustainable development goals.

Malin Corporation is a Dublin, Ireland-based venture capital investment firm focused on life sciences and healthcare technology. Founded in 2015, it backs private companies in oncology, immunology, and genetic diseases, providing long-term capital and operational expertise to accelerate growth and position portfolio firms for IPO or sale.

IQ Capital is a European deep-tech venture capital firm headquartered in Cambridge, United Kingdom. It backs founders leveraging scientific breakthroughs to build enduring global businesses and focuses on early-stage technology companies across AI, automation, computing and semiconductors, health tech, advanced engineering, energy, and security. Since 2005, the firm has invested in more than 100 ambitious deep-tech teams across multiple funds, primarily in the United Kingdom and Europe. IQ Capital provides capital and strategic guidance to help portfolio companies translate research and innovation into scalable products and global market presence.

Eden Ventures is a London-based venture capital firm focused on seed and Series A technology companies in the United Kingdom and Ireland. It backs startups across software, digital media, e-commerce, internet and mobile sectors, as well as telecommunications software and enterprise software. Founded in 2002, it targets early-stage investments and takes the early risk to support companies through development and growth, with the capacity to back follow-on rounds toward significant exits. The firm helps portfolio companies attract follow-on investors for subsequent rounds.

College Green Ventures is a venture capital firm founded in 2023 and based in Belfast, United Kingdom. It invests in early-stage university spinouts in deep technology and healthcare sectors.